Journal
NANOMEDICINE
Volume 12, Issue 16, Pages 2021-2041Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2017-0101
Keywords
carrier-mediated agents; mononuclear phagocyte system; nanoparticles; pharmacodynamics; pharmacokinetics; tumor microenvironment
Funding
- NCI NIH HHS [T32 CA196589, P30 CA016086] Funding Source: Medline
Ask authors/readers for more resources
Major advances in carrier-mediated agents, including nanoparticle, conjugates and antibody-drug conjugates, have created revolutionary drug delivery systems in cancer over the past two decades. While these agents provide several advantages, such as greater duration of exposure and solubility, compared with their small-molecule counterparts, there is substantial variability in delivery of these agents to tissues and especially tumors. This review provides an overview of tumor microenvironment factors that affect the pharmacokinetics and pharmacodynamics of carrier-mediated agents observed in preclinical models and patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available